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Background
The FHSS (a points-based scoring system) was
previously used to identify families at high risk of an
inherited colorectal cancer syndrome. AM-I
(Amsterdam-I) families scored high (≤12), but some
scored low (≥8) when scored from unaffected relative’s
perspective [1]. The FHSS is being applied to Lynch
families (MMR+) and familial colon cancer type X
(Type X) to see if the scoring system would yield simi-
lar results.
Method
Family members (1 proband, 2 siblings and 2 children of
the sibling) in Lynch and Type X families identified from
the Jagelman Registry database were scored according to
the score sheet described in Table 1.
They were scored from perspective of an affected
p r o b a n d( A P )o ru n a f f e c t ed proband (UP), affected
(AS) or unaffected (US) sibling or a child of each sib-
ling (Child).
Results
91 probands (68 affected, 23 unaffected) in 48 AM-I, 14
Amsterdam-II (AM-II), 6 Amsterdam-Like (AM-Like),
10 Familial Colon Cancer (FCC), 6 no syndrome (syn)
families and 7 Type X were scored. 197 relatives were
scored (38 affected siblings, 23 Child AP/AS, 40 Child
AP/US, 77 unaffected siblings, 9 Child UP/AS, 10 Child
UP/US). AM-I and Type X median scores were higher
than other syndromes (<12) and suggestive of HNPCC
when scored from the perspective of the proband, sib-
ling or child of AS. The median scores were lower in
AM-II, FCC, AM-Like, and no syn families with fewer
colon cancers (Table 2).
Conclusion
Findings were similar to validation study conducted on
AM-I families. The FHSS is a reliable tool to determine
familial risk of colorectal cancer especially in AM-I
families and depends on the perspective of person being
scored. In small families, those with predominantly extra
colonic cancers or high-risk polyps, or if affected relatives
are more than a generation from an individual, the FHHS
will not always identify high risk or Lynch families.
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Table 1
Points
Proband
Affected 3
First Degree Relatives(FDR)
Each FDR 3 each
1-FDR<50-yr, including proband) 3
1-FDR–same side family Extra 3
Second Degree relatives(SDR)
Each SDR 1 each
>1-SDR<50-yr 1
>1-SDR–same side family Extra 1*
Combination FDR and SDR
1-FDR and any SDR–same side family 2*
*only if maximum 3 points per family not exceeded.
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Table 2 Median Scores
AP AP’sA S A P ’s US Child AP’s AS Child AP’sU S U P U P ’sA S U P ’s US Child UP’s AS Child UP’sU S
Total Syndromes 14 18 14 12 4 12 15 12 7 4
AM- I 17 18 17 12 5 12 16 12 9 4
Type X 14 17 14 14 4 12 15 12
AM-II 12 12 12 7 2 13 13 15 9 5
FCC 12 13 9 10 2 10 10 8 8 10
AM-LIKE 12 12 4 4 4 1
No-Syn 6 6 2 6 6 6
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